Alnylam Pharmaceuticals (ALNY) Net Equity Issued and Repurchased (2012 - 2019)
Alnylam Pharmaceuticals' (ALNY) quarterly Net Equity Issued and Repurchased came in at -$18.1 million in Q2 2019, down 104.74% on a QoQ basis from $381.9 million in Q1 2019.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Net Equity Issued and Repurchased (2012 - 2019) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has 5 years of Net Equity Issued and Repurchased data on file, last reported at -$18.1 million in Q2 2019.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$18.1 million in Q2 2019, while the trailing twelve-month figure through Mar 2020 was -$18.1 million (down 101.55% YoY) and the FY2019 annual result came in at $381.9 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased slipped to -$18.1 million in Q2 2019, from $381.9 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $784.5 million in Q4 2017 to a low of -$18.1 million in Q2 2019.
- A 3-year average of $411.2 million and a median of $439.2 million in 2015 frame the typical range for Net Equity Issued and Repurchased.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.57 Bn | 21.03 Bn | 1.57 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -18.10 Mn |
| Mar 31, 2019 | 381.90 Mn |
| Dec 31, 2017 | 784.48 Mn |
| Mar 31, 2015 | 496.40 Mn |
| Mar 31, 2013 | 173.57 Mn |
| Mar 31, 2012 | 86.80 Mn |